Literature DB >> 9598799

Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients.

N Pandis1, M R Teixeira, A Adeyinka, H Rizou, G Bardi, F Mertens, J A Andersen, L Bondeson, K Sfikas, H Qvist, N Apostolikas, F Mitelman, S Heim.   

Abstract

Chromosome banding analysis of primary tumors and axillary lymph node metastases from 10 breast cancer patients revealed abnormal karyotypes in all samples with cytogenetic similarities between the primary tumor and the metastasis in all informative pairs. Although karyotypically unrelated clones were also found in the lymph node samples, they were less numerous than in the primary tumors, indicating that there was more genetic heterogeneity among the neoplastic cells in the primary than in the secondary tumors. On the other hand, some of the clones had become more complex in the metastases as a result of clonal evolution, and by and large these metastatic breast cancer cases had more karyotypic anomalies than do unselected primary breast carcinomas. Among the aberrations occurring more frequently, and that consequently may predispose to disease spread, were losses of chromosomes 17 and 22 and homogeneously staining regions, a cytogenetic sign of gene amplification.

Entities:  

Mesh:

Year:  1998        PMID: 9598799

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management.

Authors:  Dimitra Pantou; Haroula Tsarouha; Anna Papadopoulou; Louiza Mahaira; Ioannis Kyriazoglou; Nikiforos Apostolikas; Sophia Markidou; Theoni Trangas; Nikos Pandis; Georgia Bardi
Journal:  Neoplasia       Date:  2003 Jan-Feb       Impact factor: 5.715

3.  Aberrations of ERBB2 and TOP2A genes in breast cancer.

Authors:  Kirsten Vang Nielsen; Sven Müller; Susanne Møller; Andreas Schønau; Eva Balslev; Ann S Knoop; Bent Ejlertsen
Journal:  Mol Oncol       Date:  2009-11-18       Impact factor: 6.603

4.  From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression.

Authors:  Oleg Schmidt-Kittler; Thomas Ragg; Angela Daskalakis; Martin Granzow; Andre Ahr; Thomas J F Blankenstein; Manfred Kaufmann; Joachim Diebold; Hans Arnholdt; Peter Muller; Joachim Bischoff; Detlev Harich; Gunter Schlimok; Gert Riethmuller; Roland Eils; Christoph A Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

Review 5.  Metastasis: new perspectives on an old problem.

Authors:  Sandra Kraljevic Pavelic; Mirela Sedic; Hrvojka Bosnjak; Sime Spaventi; Kresimir Pavelic
Journal:  Mol Cancer       Date:  2011-02-22       Impact factor: 27.401

Review 6.  Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.

Authors:  Katrina M Piemonte; Lindsey J Anstine; Ruth A Keri
Journal:  Endocrinology       Date:  2021-12-01       Impact factor: 5.051

Review 7.  Breast cancer intra-tumor heterogeneity.

Authors:  Luciano G Martelotto; Charlotte K Y Ng; Salvatore Piscuoglio; Britta Weigelt; Jorge S Reis-Filho
Journal:  Breast Cancer Res       Date:  2014-05-20       Impact factor: 6.466

8.  Inherent variability of cancer-specific aneuploidy generates metastases.

Authors:  Mathew Bloomfield; Peter Duesberg
Journal:  Mol Cytogenet       Date:  2016-12-16       Impact factor: 2.009

Review 9.  Occurrence of cancer at multiple sites: towards distinguishing multigenesis from metastasis.

Authors:  Wei-Kang Zhang; Chun Zhang; Jing J Zhang; Shi V Liu
Journal:  Biol Direct       Date:  2008-04-11       Impact factor: 4.540

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.